Reply to Egesta Lopci, Arturo Chiti, and Massimo Lazzeri's Letter to the Editor re: Laura Evangelista, Alberto Briganti, Stefano Fanti, et al. New Clinical Indications for 18F/11C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature. Eur Urol 2016;70:161-75

Reply to Egesta Lopci, Arturo Chiti, and Massimo Lazzeri's Letter to the Editor re: Laura Evangelista, Alberto Briganti, Stefano Fanti, et al. New Clinical Indications for ¹⁸F/¹¹C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature. Eur Urol 2016;70:161-75

Eur Urol. 2016 Oct;70(4):e114-e115. doi: 10.1016/j.eururo.2016.03.024. Epub 2016 Mar 26.

¹ Nuclear Medicine and Molecular Imaging Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. Electronic address: laura.evangelista@ioveneto.it.
² Service of Nuclear Medicine, Policlinico S. Orsola-Malpighi, University of Bologna, Bologna, Italy.
³ Nuclear Medicine Department, IRCCS San Raffaele Scientific Institute, Milan, Italy.

No abstract available